SECOND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT ANALYSIS

被引：0
|
作者：
Saadaoui, K. [1 ]
Sahli, H. [1 ]
Jemmali, S. [1 ]
Boussaid, S. [1 ]
Rekik, S. [1 ]
Cheour, E. [1 ]
Elleuch, M. [1 ]
机构：
[1] La Rabta Hosp, Rheumatol, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0238
引用
收藏
页码：1144 / 1145
页数：2
相关论文
共 50 条
  • [41] ULTRASONOGRAPHIC FINDINGS IN AN INCEPTION COHORT OF 175 DMARD NAIVE RHEUMATOID ARTHRITIS PATIENTS
    Aga, A. -B.
    Lie, E.
    Uhlig, T.
    Hammer, H. B.
    van der Heijde, D.
    Kvien, T. K.
    Haavardsholm, E. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 111 - 112
  • [42] TREAT TO TARGET OUTCOMES WITH CONVENTIONAL DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, Pedro
    Villarreal, Laura
    Gomez, Danny
    Castillo, Edwin
    Giraldo, Rodrigo
    Farietta, Sandra
    Cardozo, Eva
    Castro, Carlos
    Buitrago, Diana
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S88 - S88
  • [43] Combination DMARD therapy for rheumatoid arthritis: Apparent universal acceptance.
    ODell, J
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 119 - 119
  • [44] The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
    Mao Mao An
    Zui Zou
    Hui Shen
    Jun Dong Zhang
    Yong Bing Cao
    Yuan Ying Jiang
    European Journal of Clinical Pharmacology, 2010, 66 : 49 - 59
  • [45] ADDITIVE 2-DMARD THERAPY OF THE PATIENTS WITH RHEUMATOID-ARTHRITIS
    YASUDA, M
    NONAKA, S
    WADA, T
    YAMAMOTO, M
    SHIOKAWA, S
    SUENAGA, Y
    NOBUNAGA, M
    CLINICAL RHEUMATOLOGY, 1994, 13 (03) : 446 - 454
  • [46] Novel DMARD monotherapy in rheumatoid arthritis
    Molto, Anna
    Dougados, Maxime
    LANCET, 2019, 393 (10188): : 2277 - 2278
  • [47] 15-year outcome in a cohort of early rheumatoid arthritis; analysis of a subgroup of patients with DMARD withdrawal
    Tiippana-Kinnugen, Tarja
    Paimela, Leena
    Kautiainen, Hannu
    Leirisalo-Repo, Marjatta
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 27 - 27
  • [48] TAPERING BIOLOGICAL DMARD IN RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE.
    Zuleta, W. G. Rojas
    Barbosa, M.
    Becerra-Arias, C.
    Diaz, O. J. Felipe
    Gomez, H. Donado
    Gonzalez, L. A.
    Zapata, N. Duque
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1407 - 1408
  • [49] DO PATIENTS WITH RHEUMATOID ARTHRITIS WITHOUT EXPOSURE TO BIOLOGICAL THERAPY HAVE AN INCREASED RISK FOR DEVELOPING TUBERCULOSIS ON TRADITIONAL DMARD THERAPY?
    Botha-Scheepers, S.
    Hairwadzi, H. N.
    Kalla, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 455 - 456
  • [50] Rates and predictors of DMARD use in a cohort of elderly patients with rheumatoid arthritis.
    Schmajuk, Gabriela
    Schneeweiss, Sebastian
    Katz, Jeffrey N.
    Weinblatt, Michael E.
    Setoguchi, Soko
    Avom, Jerry
    Levin, Raisa
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S342 - S343
12345